Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms of Sympathetic Overactivity in the Metabolic Syndrome: Effects of Reversing Insulin Resistance by Drug Treatment

NCT00408850 is registered in ClinicalTrials.gov with Baker Heart Research Institute as lead sponsor.

NCT NCT00408850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00408850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms of Sympathetic Overactivity in the Metabolic Syndrome: Effects of Reversing Insulin Resistance by Drug Treatment
Lead sponsor
Baker Heart Research Institute
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2008
Completion date
February 28, 2013
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome